Guideline Title
Acute change of condition in the long-term care setting.
Bibliographic Source(s)
American Medical Directors Association (AMDA). Acute change of condition in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2003. 29 p. [22 references] |
Guideline Status
This is the current release of the guideline.
This guideline was reaffirmed for currency by the developer in 2011.
UMLS Concepts ( what's this?)
Click to view all guideline(s) indexed with these concepts
Hide...
|
Disease/Condition(s)
Acute change of condition (e.g., physical, behavioral, cognitive, or functional)
Guideline Category
Evaluation
Management
Risk Assessment
Treatment
Clinical Specialty
Family Practice
Geriatrics
Internal Medicine
Intended Users
Advanced Practice Nurses
Allied Health Personnel
Dietitians
Health Care Providers
Nurses
Occupational Therapists
Pharmacists
Physical Therapists
Physician Assistants
Physicians
Social Workers
Speech-Language Pathologists
Guideline Objective(s)
- To improve the quality of care delivered to patients with an acute change of condition (ACOC) in long-term care facilities
- To guide care decisions and to define roles and responsibilities of appropriate care staff
Target Population
Elderly residents of long-term care facilities with or at risk for an acute change of condition
Note: These guidelines apply substantially to individuals who come to long-term care facilities for short-term care.
Interventions and Practices Considered
Diagnosis/Assessment
- Identifying individuals at risk for acute changes in condition (ACOCs)
- Describing and documenting symptoms and/or condition changes
- Defining patient’s stability and identifying why the situation is problematic
- Determining the feasibility of identifying the causes(s) of the ACOC in the facility
- Identifying and documenting the likely causes of the ACOC
Management/Treatment
- Determining the feasibility of managing the ACOC in the facility
- Identifying appropriate treatment goals and objectives that consider the patient's wishes
- Managing the ACOC
- Monitoring the patient's progress
- Adjusting interventions and goals based on the patient's response to treatment
- Reviewing the facilities management of ACOCs and unplanned hospital transfers
Major Outcomes Considered
Hospital admissions from long-term care facilities
|
Methods Used to Collect/Select the Evidence
Searches of Electronic Databases
Description of Methods Used to Collect/Select the Evidence
2003 Guideline
Not stated
2011 Review Process
MEDLINE and PubMed were searched for updated literature related to the subject published between June 2009 and January 2011. This search is done annually and completed by the clinical practice committee vice-chair. If new literature does not change the content or scope of the original guideline, it is deemed to be current.
Number of Source Documents
Methods Used to Assess the Quality and Strength of the Evidence
Expert Consensus
Rating Scheme for the Strength of the Evidence
Methods Used to Analyze the Evidence
Review
Description of the Methods Used to Analyze the Evidence
Methods Used to Formulate the Recommendations
Expert Consensus
Description of Methods Used to Formulate the Recommendations
The guideline was developed by an interdisciplinary work group using a process that combined evidence- and consensus-based thinking. The groups were composed of practitioners involved in patient care in the institutional setting. Using pertinent articles and information and a draft outline, the group worked to make a simple, user-friendly guideline that focused on application in the long-term care institutional setting.
Rating Scheme for the Strength of the Recommendations
Cost Analysis
A formal cost analysis was not performed and published cost analyses were not reviewed.
Method of Guideline Validation
External Peer Review
Internal Peer Review
Description of Method of Guideline Validation
All American Medical Directors Association (AMDA) clinical practice guidelines undergo external review. The draft guideline is sent to approximately 175+ reviewers. These reviewers include AMDA physician members and independent physicians, specialists, and organizations that are knowledgeable of the guideline topic and the long-term care setting.
|
Major Recommendations
The algorithm Acute Change of Condition (ACOC) in the long-term care setting is to be used in conjunction with the clinical practice guideline. The numbers next to the different components of the algorithm correspond with the steps in the text. Refer to the "Guideline Availability" field for information on obtaining the full text guideline.
|
Evidence Supporting the Recommendations
Type of Evidence Supporting the Recommendations
The guideline was developed by an interdisciplinary work group using a process that combined evidence- and consensus-based thinking.
|
Benefits/Harms of Implementing the Guideline Recommendations
Potential Benefits
The approach to recognition, assessment, treatment, and monitoring of acute changes of condition (ACOCs) that is proposed in this guideline should result in better management of these events in the long-term care facility and fewer transfers to hospitals and other acute-care settings.
|
Qualifying Statements
- This clinical practice guideline is provided for discussion and educational purposes only and should not be used or in any way relied upon without consultation with and supervision of a qualified physician based on the case history and medical condition of a particular patient. The American Medical Directors Association, its heirs, executors, administrators, successors, and assigns hereby disclaim any and all liability for damages of whatever kind resulting from the use, negligent or otherwise, of this clinical practice guideline.
- The utilization of the American Medical Director Association’s Clinical Practice Guideline does not preclude compliance with State and Federal regulation as well as facility policies and procedures. They are not substitutes for the experience and judgment of clinicians and care-givers. The Clinical Practice Guidelines are not to be considered as standards of care but are developed to enhance the clinician's ability to practice.
|
Implementation of the Guideline
Description of Implementation Strategy
The implementation of this clinical practice guideline (CPG) is outlined in four phases. Each phase presents a series of steps, which should be carried out in the process of implementing the practices presented in this guideline. Each phase is summarized below.
- Recognition
- Define the area of improvement and determine if there is a CPG available for the defined area. Then evaluate the pertinence and feasibility of implementing the CPG.
- Assessment
- Define the functions necessary for implementation and then educate and train staff. Assess and document performance and outcome indicators and then develop a system to measure outcomes.
- Implementation
- Identify and document how each step of the CPG will be carried out and develop an implementation timetable.
- Identify individual responsible for each step of the CPG.
- Identify support systems that impact the direct care.
- Educate and train appropriate individuals in specific CPG implementation and then implement the CPG.
- Monitoring
- Evaluate performance based on relevant indicators and identify areas for improvement.
- Evaluate the predefined performance measures and obtain and provide feedback.
Implementation Tools
Clinical Algorithm
Tool KitsFor information about availability, see the Availability of Companion Documents and Patient Resources fields below.
|
Institute of Medicine (IOM) National Healthcare Quality Report Categories
IOM Care Need
Getting Better
IOM Domain
Effectiveness
Patient-centeredness
Timeliness
|
Identifying Information and Availability
Bibliographic Source(s)
American Medical Directors Association (AMDA). Acute change of condition in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2003. 29 p. [22 references] |
Adaptation
Not applicable: The guideline was not adapted from another source.
Date Released
2003 (reaffirmed 2011)
Guideline Developer(s)
American Medical Directors Association - Professional Association
Guideline Developer Comment
Organizational participants included:
- American Association of Homes and Services for the Aging
- American College of Health Care Administrators
- American Geriatrics Society
- American Health Care Association
- American Society of Consultant Pharmacists
- National Association of Directors of Nursing Administration in Long-Term Care
- National Association of Geriatric Nursing Assistants
- National Conference of Gerontological Nurse Practitioners
Source(s) of Funding
American Medical Directors Association
Composition of Group That Authored the Guideline
Naushira Pandya, MD, CMD, Project Chair>
Steven Levenson, MD, CMD, Clinical Practice Committee Chair
Steering Committee Members: Donna Brickley, RN; Lisa Cantrell, RN, C; Charles Cefalu, MD, MS; Sherrie Dornberger, RNC, FADONA; Sandra Fitzler, RN; Joseph Gruber, RPh, FASCP, CGP; Larry Lawhorne, MD, CMD; Steven Levenson, MD, CMD; Susan M. Levy, MD, CMD; Harlan Martin, RPh, CCP, FASCP; Geri Mendelson, RN, CNAA, MEd, NHA; Evvie F. Munley; Jonathan Musher, MD, CMD; Mary Tellis-Nayak RN, MSN; Barbara Resnick, PhD, CRNP; William Simonson, PharmD, FASCP, CGP
Financial Disclosures/Conflicts of Interest
Guideline Status
This is the current release of the guideline.
This guideline was reaffirmed for currency by the developer in 2011.
Guideline Availability
Electronic copies: None available
Print copies: Available from the American Medical Directors Association, 10480 Little Patuxent Pkwy, Suite 760, Columbia, MD 21044. Telephone: (800) 876-2632 or (410) 740-9743; Fax (410) 740-4572. Web site: www.amda.com .
Availability of Companion Documents
The following are available:
- Guideline implementation: clinical practice guidelines. Columbia, MD: American Medical Directors Association, 1998, 28 p.
- We care: implementing clinical practice guidelines tool kit. Columbia, MD: American Medical Directors Association, 2003.
Electronic copies: None available
Print copies: Available from the American Medical Directors Association, 10480 Little Patuxent Pkwy, Suite 760, Columbia, MD 21044. Telephone: (800) 876-2632 or (410) 740-9743; Fax (410) 740-4572. Web site: www.amda.com .
NGC Status
This NGC summary was completed by ECRI on July 6, 2004. The information was verified by the guideline developer on August 4, 2004. The currency of the guideline was reaffirmed by the developer in 2011 and this summary was updated by ECRI Institute on May 11, 2012.
Copyright Statement
This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. For more information, please contact the American Medical Directors Association (AMDA) at (800) 876-2632.
|
NGC Disclaimer
The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site. Read full disclaimer...The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.
All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.
Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion-criteria.aspx.
NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.
Readers with questions regarding guideline content are directed to contact the guideline developer. Hide...
|